drugset / Trial / NCT05004038

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

NCT05004038

Phase 2 Completed 60 enrolled University of Zurich
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A phase IIA randomized double-blind placebo-controlled single-centre study of the effect of Bacillus Calmette-Guérin (BCG) vaccination on the HIV latent reservoir

Timeline

Start
2022-01-04
Primary completion
2023-09-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator BCG vaccine Vaccine Other